These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7035666)

  • 1. Future directions in dopaminergic nervous system and dopaminergic agonists.
    Cannon JG; Long JP; Bhatnagar R
    J Med Chem; 1981 Oct; 24(10):1113-8. PubMed ID: 7035666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-(Aminoalkyl)-7-hydroxy-2(3H)-indolones, a novel class of potent presynaptic dopamine receptor agonists.
    Huffman WF; Hall RF; Grant JA; Wilson JW; Hieble JP; Hahn RA
    J Med Chem; 1983 Jul; 26(7):933-5. PubMed ID: 6306238
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
    Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M
    Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dopaminergic system in opioid-induced cardiovascular responses in dogs.
    Agarwal RK; Pandey US; Dixit KS; Shukla N; Singh SK
    Indian J Med Sci; 1989 Dec; 43(12):323-8. PubMed ID: 2632409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine: pharmacologic and therapeutic aspects.
    Velasco M; Luchsinger A
    Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area.
    Mercuri NB; Calabresi P; Bernardi G
    Life Sci; 1992; 51(10):711-8. PubMed ID: 1355254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs.
    Barrett RJ; Lokhandwala MF
    Eur J Pharmacol; 1983 Dec; 96(3-4):211-26. PubMed ID: 6676105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complex.
    Charbit AR; Akerman S; Goadsby PJ
    J Pharmacol Exp Ther; 2009 Nov; 331(2):752-63. PubMed ID: 19657051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological studies on the interrelation between the dopaminergic, GABAergic and opioid peptidergic systems in the central nervous system of the rat.
    Kamata K
    Jpn J Pharmacol; 1987 Dec; 45(4):439-47. PubMed ID: 2832648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dopaminergic regulation of the renin-angiotensin-aldosterone system (RAAS). The control of the initial components of the RAAS (a review of the literature)].
    Markov VV; Rudychenko VM; Tron'ko MD
    Lik Sprava; 1992 Sep; (9):9-14. PubMed ID: 1362308
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of repeated treatment with milnacipran on the central dopaminergic system.
    Rogóz Z; Margas W; Dlaboga D; Góralska M; Dziedzicka-Wasylewska M; Maj J
    Pol J Pharmacol; 2000; 52(2):83-92. PubMed ID: 10949109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-2 dopamine autoreceptor selective drugs: do they really exist?
    Drukarch B; Stoof JC
    Life Sci; 1990; 47(5):361-76. PubMed ID: 1975636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists.
    Skirboll LR; Grace AA; Bunney BS
    Science; 1979 Oct; 206(4414):80-2. PubMed ID: 482929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
    Ensinger H; Majewski H; Hedler L; Starke K
    J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology.
    Chiodo LA
    Neurosci Biobehav Rev; 1988; 12(1):49-91. PubMed ID: 3287242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dopaminergic receptors: structural features and functional implications].
    Nieoullon A; Amalric M
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S59-68. PubMed ID: 12690665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interrelationship of the tranquilizers diazepam and lonetil with dopamine mediation in the central nervous system].
    Ovcharov R; Danchev N
    Eksp Med Morfol; 1981; 20(2):88-96. PubMed ID: 7250025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system.
    Willems JL; Buylaert WA; Lefebvre RA; Bogaert MG
    Pharmacol Rev; 1985 Jun; 37(2):165-216. PubMed ID: 2996038
    [No Abstract]   [Full Text] [Related]  

  • 19. Relevance of dopamine autoreceptors for psychiatry: preclinical and clinical studies.
    Meltzer HY
    Schizophr Bull; 1980; 6(3):456-75. PubMed ID: 6105707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview.
    Missale C; Lombardi C; De Cotiis R; Memo M; Carruba MO; Spano PF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S29-39. PubMed ID: 2483440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.